Chemosensitisation By, and Single Agent Activity of, ATR Inhibitor VE-821 in Human Breast Cancer Cells

被引：0
|
作者：
Middleton, F. K. [1 ]
Chen, T. [1 ]
Pollard, J. R. [2 ]
Curtin, N. J. [1 ]
机构：
[1] Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[2] Vertex Pharmaceut, Oxford, England
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
10.1016/S0959-8049(12)72076-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
278
引用
收藏
页码：85 / 86
页数：2
相关论文
共 50 条
  • [21] Targeting ATR using a novel ATR inhibitor AZD6738 in human gastric cancer cells
    Min, Ahrum
    Im, Seock-Ah
    Jang, Hyemin
    Kim, Seongyeong
    Lee, Miso
    Kim, Jungeun
    Lee, Kyung-Hun
    Han, Sae-Won
    Kim, Tae-Young
    Oh, Do-Youn
    Kim, Tae-You
    Kim, Woo-Ho
    Bang, Yung-Jue
    CANCER RESEARCH, 2015, 75
  • [22] Elaiophylin, a novel autophagy inhibitor, exerts antitumor activity as a single agent in ovarian cancer cells
    Zhao, Xuejiao
    Fang, Yong
    Yang, Yang
    Qin, Yu
    Wu, Peng
    Wang, Ting
    Lai, Huiling
    Meng, Li
    Wang, Daowen
    Zheng, Zhihui
    Lu, Xinhua
    Zhang, Hua
    Gao, Qinglei
    Zhou, Jianfeng
    Ma, Ding
    AUTOPHAGY, 2015, 11 (10) : 1849 - 1863
  • [23] ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation
    Fokas, E.
    Prevo, R.
    Pollard, J. R.
    Reaper, P. M.
    Charlton, P.
    Cornelissen, B.
    Vallis, K.
    Hammond, E. M.
    Olcina, M. M.
    McKenna, W. G.
    Muschel, R. J.
    Brunner, T. B.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 : 41 - 41
  • [24] Anti-tumor activity of the ATR inhibitor AZD6738 in HER2 positive breast cancer cells
    Kim, Hee-Jun
    Min, Ahrum
    Im, Seock-Ah
    Jang, Hyemin
    Lee, Kyung Hun
    Lau, Alan
    Lee, Miso
    Kim, Seongyeong
    Yang, Yaewon
    Kim, Jungeun
    Kim, Tae Yong
    Oh, Do-Youn
    Brown, Jeffrey
    O'Connor, Mark J.
    Bang, Yung-Jue
    INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (01) : 109 - 119
  • [25] Activity of the Cdc7 inhibitor NMS-1116354 as single agent and in combination in breast cancer models
    Montagnoli, A.
    Ballinari, D.
    Ciavolella, A.
    Rainoldi, S.
    Menichincheri, M.
    Pesenti, E.
    Galvani, A.
    Isacchi, A.
    Moll, J.
    EJC SUPPLEMENTS, 2010, 8 (07): : 49 - 49
  • [26] The peroxisome proliferator-activated receptor γ is an inhibitor of ErbBs activity in human breast cancer cells
    Pignatelli, M
    Cortés-Canteli, M
    Lai, C
    Santos, A
    Perez-Castillo, A
    JOURNAL OF CELL SCIENCE, 2001, 114 (22) : 4117 - 4126
  • [27] Targeting radioresistant breast cancer cells by single agent CHK1 inhibitor via enhancing replication stress
    Zhang, Yao
    Lai, Jinzhi
    Du, Zhanwen
    Gao, Jinnan
    Yang, Shuming
    Gorityala, Shashank
    Xiong, Xiahui
    Deng, Ou
    Ma, Zhefu
    Yan, Chunhong
    Susana, Gonzalo
    Xu, Yan
    Zhang, Junran
    ONCOTARGET, 2016, 7 (23) : 34688 - 34702
  • [28] A novel endocrine-disrupting agent in corn with mitogenic activity in human breast and prostatic cancer cells
    Markaverich, B
    Mani, S
    Alejandro, MA
    Mitchell, A
    Markaverich, D
    Brown, T
    Velez-Trippe, C
    Murchison, C
    O'Malley, B
    Faith, R
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2002, 110 (02) : 169 - 177
  • [29] Oxidosqualene Cyclase Inhibitor Suppresses Transcriptional Activity of Estrogen Receptor-α in Human Breast Cancer Cells
    Mafuvadze, Benford
    Liang, Yayun
    Hyder, Salman M.
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [30] Anticancer Activity of Protocatechualdehyde in Human Breast Cancer Cells
    Choi, Jieun
    Jiang, Xiaojing
    Jeong, Jin Boo
    Lee, Seong-Ho
    JOURNAL OF MEDICINAL FOOD, 2014, 17 (08) : 842 - 848
12345